Skip to content
ZE1ZE1ZE1

Drawing based on the label description. No photo yet.

“Tablets. 12.5 mg tablets - Round, biconvex, white color, film coated tablets debossed with 'ZE1' on one side and plain on other side”

ZE1 pill

Pill with imprint ZE1 is white, round, 6 mm and has been identified as Eltrombopag Olamine 12.5 mg. It is used for aplastic anemia and idiopathic thrombocytopenic purpura. It is supplied by Hikma Pharmaceuticals USA Inc.

Eltrombopag Olamine 12.5 mg

Imprint
ZE1
Strength
12.5 mg
Used for
Aplastic anemia and idiopathic thrombocytopenic purpura
Color
White
Shape
Round
Size
6 mm
Score
No score line
Form
Tablet
Manufacturer
Hikma Pharmaceuticals USA Inc
Drug class
Thrombopoietin receptor agonist
NDC
0054-0962, 0054-0962-13

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Eltrombopag Olamine pills and guides

What is Eltrombopag Olamine used for?

Eltrombopag Olamine is used for aplastic anemia and idiopathic thrombocytopenic purpura.

Medicine type
Thrombopoietin receptor agonist
Official uses from the US prescribing label

Treatment of Thrombocytopenia in Patients With Persistent or Chronic Immune Thrombocytopenia

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in adult and pediatric patients 1 year and older with persistent or chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins, or splenectomy. Eltrombopag tablets should be used only in patients with ITP whose degree of thrombocytopenia and clinical condition increase the risk for bleeding.

Treatment of Thrombocytopenia in Patients With Hepatitis C Infection

Eltrombopag tablets are indicated for the treatment of thrombocytopenia in patients with chronic hepatitis C to allow the initiation and maintenance of interferon-based therapy. Eltrombopag tablets should be used only in patients with chronic hepatitis C whose degree of thrombocytopenia prevents the initiation of interferon-based therapy or limits the ability to maintain interferon-based therapy.

Treatment of Severe Aplastic Anemia

  • Eltrombopag tablets are indicated in combination with standard immunosuppressive therapy (IST) for the first-line treatment of adult and pediatric patients 2 years and older with severe aplastic anemia.
  • Eltrombopag tablets are indicated for the treatment of patients with severe aplastic anemia who have had an insufficient response to immunosuppressive therapy.

Limitations of Use

  • Eltrombopag tablets are not indicated for the treatment of patients with myelodysplastic syndromes (MDS).
  • Safety and efficacy have not been established in combination with direct-acting antiviral agents used without interferon for treatment of chronic hepatitis C infection.

From the FDA-approved label on DailyMed (published Sep 14, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • One side shows ZE1 and the other side is plain.
  • It is white, round, 6 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Eltrombopag.

Ingredients

Active: Eltrombopag Olamine

Inactive: Silicon Dioxide, Magnesium Stearate, Mannitol, Silicified Microcrystalline Cellulose (125 .micro.m, High-Density), Crospovidone, Unspecified, Starch, Corn, Sodium Starch Glycolate Type A Potato, Ferric Oxide Red, Hypromellose, Unspecified, Polyethylene Glycol 400, Polysorbate 80, Titanium Dioxide, Ferrosoferric Oxide

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Eltrombopag Olamine pills